Clinical trials
Neurodevelopmental Disorders trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 5 |
| Not yet recruiting | 4 |
| Active, not recruiting | 3 |
| Completed | 3 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sun Yat-sen University | 5 |
| Longboard Pharmaceuticals | 3 |
| Fudan University | 2 |
| Aiyoudong Children and Youth Sports Health Research Institute | 1 |
| Chinese University of Hong Kong | 1 |
| Dong-Xin Wang | 1 |
| Guangzhou Women and Children's Medical Center | 1 |
| Qilu Hospital of Shandong University | 1 |
| University of Macau | 1 |
| Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neurodevelopmental Disorders | 17 |
| Epilepsy | 3 |
| Pregnancy Complications | 3 |
| Premature Birth | 3 |
| Seizures | 3 |
| Diabetes, Gestational | 2 |
| Dysbiosis | 2 |
| Epilepsies, Myoclonic | 2 |
| Lennox Gastaut Syndrome | 2 |
| Obesity | 2 |
Trials
Showing 51 to 17 of 17. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.